OVID THERAPEUTICS INC. - COMMON STOCK
3.0000
10-5月-24 14:59:51
15 分の遅延
株式
-0.0500
-1.64%
本日の幅
3.0000 - 3.0600
ISIN
N/A
ソース
NASDAQ
-
Ovid Therapeutics Reports Second Quarter 2021 Financial Results and Corporate Highlights
16 8 2021 07:00:02 提供 Nasdaq GlobeNewswire
-
08 7 2021 15:30:00 提供 Nasdaq GlobeNewswire
-
Ovid Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference
07 7 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Ovid Therapeutics Appoints Jeff Rona as Chief Business and Financial Officer
04 6 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
26 5 2021 07:00:02 提供 Nasdaq GlobeNewswire
-
Ovid Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
13 5 2021 15:05:01 提供 Nasdaq GlobeNewswire
-
Ovid Therapeutics to Participate in the 2021 RBC Capital Markets Global Healthcare Conference
12 5 2021 07:00:02 提供 Nasdaq GlobeNewswire
-
20 4 2021 07:00:02 提供 Nasdaq GlobeNewswire
-
OVID Provides Update on OV101 Program and the Prioritization of its Resources
19 4 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
30 3 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
15 3 2021 07:00:02 提供 Nasdaq GlobeNewswire